Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of acute memantine administration on MATRICS Consensus Cognitive Battery performance in psychosis: Testing an experimental medicine strategy
Savita G. Bhakta, Hsun‐Hua Chou, Brinda K. Rana, et al.
Psychopharmacology (2016) Vol. 233, Iss. 12, pp. 2399-2410
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
Thomas R. E. Barnes, Richard Drake, Carol Paton, et al.
Journal of Psychopharmacology (2019) Vol. 34, Iss. 1, pp. 3-78
Open Access | Times Cited: 505
Cognitive Impairment Associated with Schizophrenia: From Pathophysiology to Treatment
Daniel C. Javitt
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 119-141
Open Access | Times Cited: 64
Anticholinergic Burden and Cognitive Function in Psychosis: A Systematic Review and Meta-Analysis
Valentina Mancini, Caren Latrèche, Jack B. Fanshawe, et al.
American Journal of Psychiatry (2025)
Closed Access | Times Cited: 1
Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia
Gregory A. Light, Wen Zhang, Yash B. Joshi, et al.
Neuropsychopharmacology (2017) Vol. 42, Iss. 13, pp. 2633-2639
Open Access | Times Cited: 67
Technology and Mental Health: State of the Art for Assessment and Treatment
Philip D. Harvey, Colin A. Depp, Albert Rizzo, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 12, pp. 897-914
Closed Access | Times Cited: 34
Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis
Taro Kishi, Yuki Matsuda, Nakao Iwata
Psychopharmacology (2017) Vol. 234, Iss. 14, pp. 2113-2125
Closed Access | Times Cited: 42
N-methyl-d-aspartate-type glutamate receptor modulators and related medications for the enhancement of auditory system plasticity in schizophrenia
Joshua T. Kantrowitz
Schizophrenia Research (2018) Vol. 207, pp. 70-79
Closed Access | Times Cited: 41
Finding the Right Dose: NMDA Receptor–Modulating Treatments for Cognitive and Plasticity Deficits in Schizophrenia and the Role of Pharmacodynamic Target Engagement
Pejman Sehatpour, Joshua T. Kantrowitz
Biological Psychiatry (2024) Vol. 97, Iss. 2, pp. 128-138
Closed Access | Times Cited: 4
Room to move: Plasticity in early auditory information processing and auditory learning in schizophrenia revealed by acute pharmacological challenge
Neal R. Swerdlow, Savita G. Bhakta, Gregory A. Light
Schizophrenia Research (2018) Vol. 199, pp. 285-291
Open Access | Times Cited: 37
The Mismatch Negativity
Risto Näätänen, Teija Kujala, Gregory A. Light
Oxford University Press eBooks (2019)
Closed Access | Times Cited: 34
Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate–Type Glutamate Receptor Function
Joshua T. Kantrowitz, Neal R. Swerdlow, Walter Dunn, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2018) Vol. 3, Iss. 7, pp. 581-590
Open Access | Times Cited: 28
Potential Role of Antipsychotic-Galantamine-Memantine Combination in the Treatment of Positive, Cognitive, and Negative Symptoms of Schizophrenia
Maju Mathew Koola
Complex Psychiatry (2018) Vol. 4, Iss. 3, pp. 134-148
Open Access | Times Cited: 26
Neurophysiological biomarkers for schizophrenia therapeutics
Gregory A. Light, Yash B. Joshi, Juan L. Molina, et al.
Biomarkers in Neuropsychiatry (2020) Vol. 2, pp. 100012-100012
Open Access | Times Cited: 22
Implication of Electrophysiological Biomarkers in Psychosis: Focusing on Diagnosis and Treatment Response
Ho Sung Lee, Ji Sun Kim
Journal of Personalized Medicine (2022) Vol. 12, Iss. 1, pp. 31-31
Open Access | Times Cited: 13
Using EEG-Guided Basket and Umbrella Trials in Psychiatry: A Precision Medicine Approach for Cognitive Impairment in Schizophrenia
Yash B. Joshi, Gregory A. Light
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 18
Effect of mGluR2 positive allosteric modulation on frontostriatal working memory activation in schizophrenia
Daniel H. Wolf, David Zheng, Christian G. Kohler, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 2, pp. 1226-1232
Open Access | Times Cited: 13
Effects of Amphetamine on Sensorimotor Gating and Neurocognition in Antipsychotic-Medicated Schizophrenia Patients
Neal R. Swerdlow, Savita G. Bhakta, Jo Talledo, et al.
Neuropsychopharmacology (2017) Vol. 43, Iss. 4, pp. 708-717
Open Access | Times Cited: 16
Adjunctive Memantine Treatment of Schizophrenia
Fatemeh Hassanpour, Mehran Zarghami, S Mouodi, et al.
Journal of Clinical Psychopharmacology (2019) Vol. 39, Iss. 6, pp. 634-638
Closed Access | Times Cited: 15
Symptomatic thinking: the current state of Phase III and IV clinical trials for cognition in schizophrenia
John C. Talpos
Drug Discovery Today (2017) Vol. 22, Iss. 7, pp. 1017-1026
Closed Access | Times Cited: 12
A role for endothelial NMDA receptors in the pathophysiology of schizophrenia
Katheron Intson, Salma Geissah, Robert E. McCullumsmith, et al.
Schizophrenia Research (2020) Vol. 249, pp. 63-73
Closed Access | Times Cited: 10
A method for diagnosis support of mild cognitive impairment through EEG rhythms source location during working memory tasks
Rodrigo San-Martin, Erin Johns, Godofredo Quispe Mamani, et al.
Biomedical Signal Processing and Control (2021) Vol. 66, pp. 102499-102499
Closed Access | Times Cited: 9
Grant Report on d-Serine Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia †.
Natalie de la Garrigue, Juliana Glasser, Pejman Sehatpour, et al.
PubMed (2020) Vol. 5, Iss. 4
Closed Access | Times Cited: 6
The mismatch negativity (MMN): An introduction
Risto Näätänen, Teija Kujala, Gregory A. Light
Oxford University Press eBooks (2019), pp. 1-40
Closed Access | Times Cited: 4
Neuregulin1 gene variants as a biomarker for cognitive impairments in patients with schizophrenia
Esmaeil Shahsavand Ananloo, Sadegh Yoosefee, Mojtaba Karimipour
The European Journal of Psychiatry (2020) Vol. 34, Iss. 1, pp. 11-19
Closed Access | Times Cited: 4
Using Biomarkers to Predict Memantine Effects in Alzheimer’s Disease: A Proposal and Proof-Of-Concept Demonstration
Neal R. Swerdlow, J Kotz, Yash B. Joshi, et al.
Journal of Alzheimer s Disease (2021) Vol. 84, Iss. 4, pp. 1431-1438
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top